Whereas menstruation impacts half the world’s inhabitants, dependable instruments to objectively measure menstrual move and monitor cycle patterns have been just about absent. Present options depend on self-reporting or on merchandise that present no actionable information, leaving thousands and thousands with out the means to grasp their very own our bodies or to have knowledgeable discussions with healthcare professionals.
Emm’s reply is the world’s first sensible menstrual cup linked to an app, which gives customers with exact, personalised insights into move quantity, cycle regularity, and different well being alerts.
Backed by a $9 million seed funding spherical led by Lunar Ventures, alongside contributions from the Labcorp Enterprise Fund, Tiny VC, BlueLion International, Alumni Ventures, and angel traders together with Amar Shah, Vivek Garipalli, and Harpreet Rai, Emm is getting ready to carry this groundbreaking know-how to the UK market in early 2026.
The world’s first sensible menstrual cup
The corporate was based in 2020 by Jenny Button, who seen how menstrual well being has been ignored within the quickly evolving subject of wearable well being know-how.
With the conviction that menstruation deserves measurement and understanding similar to cardiovascular or metabolic well being, Button got down to develop an answer that empowers folks with correct information to affect their wellbeing and healthcare.
Emm’s flagship product is a menstrual cup crafted from medical-grade silicone, embedded with ultra-thin sensors to measure menstrual move and monitor cycle traits objectively. The system has been fine-tuned over 5 years via 1000’s of design iterations and intensive person suggestions, making certain consolation, reliability, and precision.
Its linked app routinely collects information, establishing a baseline inside three cycles and unlocking insights into cycle length, regularity, and abnormalities that customers can act on.
Not like opponents comparable to Clue or Flo Health, which rely closely on handbook monitoring or oblique physiological alerts, Emm combines sensor {hardware} and software program to ship clinical-grade information in a user-friendly type.
What’s subsequent?
Emm plans to launch initially within the UK in early 2026, with enlargement into worldwide markets, together with the US, within the following years.
The corporate goals to evolve its platform right into a dual-purpose instrument for customers and researchers alike, enabling new insights and breakthrough remedies for underdiagnosed menstrual and reproductive well being circumstances, comparable to endometriosis.
